Pfizer Depo-Provera “Black Box” Urges Short-Term Use Only Due To Bone Loss
Executive Summary
A "black box" warning added to Pfizer's contraceptive injection Depo-Provera (medroxyprogesterone) states the drug should be treated as second-line for long-term use due to the potential for bone loss